tradingkey.logo
tradingkey.logo
Search

Oncology Institute Inc

TOI
Add to Watchlist
4.000USD
+0.020+0.50%
Close 05/18, 16:00ETQuotes delayed by 15 min
399.90MMarket Cap
LossP/E TTM

Oncology Institute Inc

4.000
+0.020+0.50%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.50%

5 Days

-0.25%

1 Month

+12.99%

6 Months

+6.10%

Year to Date

+12.36%

1 Year

+33.78%

Key Insights

Oncology Institute Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 32 out of 74 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Oncology Institute Inc's Score

Industry at a Glance

Industry Ranking
32 / 74
Overall Ranking
160 / 4482
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Oncology Institute Inc Highlights

StrengthsRisks
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 55.05% year-on-year.
Undervalued
The company’s latest PE is -11.16, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 47.47M shares, decreasing 17.60% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 7.01K shares of this stock.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
7.000
Target Price
+75.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Oncology Institute Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Oncology Institute Inc Info

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Ticker SymbolTOI
CompanyOncology Institute Inc
CEOVirnich (Daniel)
Websitehttps://theoncologyinstitute.com/
KeyAI